Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07454122 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CD5CAR-NK Cells for Refractory Invasive Mold Disease

Study acronym: CD5CAR-NK
StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
CD5CAR-NK is a first-in-human, pilot, dose-escalation, and single-site study to evaluate the safety of CD5CAR-CBNK in patients with invasive mold diseases (IMD). The study population consists of patients aged ≥18 years with refractory mold infections. The number of patients treated will be 10. This is a dose-escalation study including 3 cohorts.
Trial Details
NCT Number NCT07454122
Lead Sponsor Fundacion Clinic per a la Recerca Biomédica
Conditions
(from sponsor)		 Fungal Infection
Related terms Mycoses
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov